TAKEDA PHARMACEUTICAL CO LTD 13D and 13G filings for Molecular Templates, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-09-14 06:13 am Sale |
2021-08-24 | 13D | Molecular Templates, Inc. MTEM |
TAKEDA PHARMACEUTICAL CO LTD | 154,311 4.100% |
-40,556 (-20.81%) |
Filing |